Search for stock quotes, financial statistics and more
Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals’ (Eupraxia Pharmaceuticals Stoc... Read More
Leede Financial analyst Douglas Loe raised his target on Eupraxia Pharmaceuticals (Eupraxia Pharmace... Read More
Andre Uddin of Research Capital maintained a “Speculative Buy” rating and C$14.00 price target o... Read More
In a Nov. 5 update, Research Capital analyst André Uddin reiterated his “Speculative Buy” ratin... Read More
Leede Financial has initiated coverage of Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Q... Read More
Share
Tweet
pin
Share